# Vaciome Pte.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/vaciome-pte

- Industry: Biotechnology
- Headquarters: Singapore
- Website: www.peptobiotics.com
- Total disclosed funding: $6.2M
- Latest round: Series A (Apr 8, 2024)
- Investors on record: 8

## About

Based in Singapore, Vaciome Pte. Ltd. dba Peptobiotics operates as a biotech company that offers synthetic biology alternatives to livestock antibiotics. Jonathan Bester is the founder and serves as the CEO of the company as of 2021. The company is funded by EF Venture Capital.

The company develops recombinant livestock feed additives as replacements for agricultural antibiotics and hormones. Its solution includes bioactive peptides that maintain their structure in the gut, fighting pathogens and optimizing intestinal health from inside the animal.

## Funding rounds

- Series A, Apr 8, 2024, $6.2M — Seventure Partners, SEEDS Capital, The Yield Lab, Trendlines Agrifood Innovation Center, HATCH, Ponderosa Ventures, Farmabase Animal Health, GrainCorp Ventures

## Investors

- Seventure Partners (https://capitalatlas.ai/funds/seventure-partners) — Series A
- SEEDS Capital (https://capitalatlas.ai/funds/seeds-capital) — Series A
- The Yield Lab (https://capitalatlas.ai/funds/the-yield-lab) — Series A
- Trendlines Agrifood Innovation Center (https://capitalatlas.ai/funds/trendlines-agrifood-innovation-center) — Series A
- HATCH — Series A
- Ponderosa Ventures (https://capitalatlas.ai/funds/ponderosa-ventures) — Series A
- Farmabase Animal Health — Series A
- GrainCorp Ventures (https://capitalatlas.ai/funds/graincorp-ventures) — Series A